EGFR, FLT1 and Heparanase as Markers Identifying Patients at Risk of Short Survival in Cholangiocarcinoma

BACKGROUND: Cholangiocarcinoma remains to be a tumor with very few treatment choices and limited prognosis. In this study, we sought to determine the prognostic role of fms-related tyrosine kinase 1/vascular endothelial growth factor receptor 1 (FLT1/VEGFR1), heparanase (HPSE) and epidermal growth f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Andreas-Claudius, Goekkurt, Eray, Danenberg, Peter V., Lehmann, Sylvia, Ehninger, Gerhard, Aust, Daniela E., Stoehlmacher-Williams, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660514/
https://www.ncbi.nlm.nih.gov/pubmed/23704979
http://dx.doi.org/10.1371/journal.pone.0064186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660514/
https://www.ncbi.nlm.nih.gov/pubmed/23704979
http://dx.doi.org/10.1371/journal.pone.0064186

Ejemplares similares